Acuvi AB (STO:ACUVI)
Sweden · Delayed Price · Currency is SEK | Market Cap | 277.85M -70.3% |
| Revenue (ttm) | 203.02M +4.7% |
| Net Income | -44.94M |
| EPS | -1.37 |
| Shares Out | 33.36M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 19,130 |
| Open | 8.25 |
| Previous Close | 8.27 |
| Day's Range | 8.09 - 8.33 |
| 52-Week Range | 8.09 - 30.65 |
| Beta | 1.15 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 3, 2026 |
About Acuvi AB
Acuvi AB provides engineering products for OEM solutions in Sweden and internationally. The company offers linear actuators, which includes Piezo LEGS vacuum capable and non-magnetic linear motors and actuators; linear and rotary stages; microplate robots; rotary piezo legs motors; controlling the actuator/motor; custom linear actuators; custom curved rail systems; and corrosion resistant telescopic slides. It also provides solutions in the field of life science instrumentations. The company was formerly known as PiezoMotor Uppsala AB (publ) an... [Read more]
Financial Performance
Financial StatementsNews
Acuvi AB Earnings Call Transcript: Q2 2026
Q2 saw net sales rise to SEK 50 million, but operating profit turned negative and gross margin dropped to 51%. Growth in PiezoMotor and Asian markets is strong, but the loss of a major U.S. deal poses a revenue challenge. Cost control and positive cash flow remain top priorities.
Acuvi AB Quarterly report: Q2 2026
Acuvi AB has published its Q2 2026 quarterly earnings report on August 20, 2026.
Acuvi AB Earnings Call Transcript: Q1 2026
Q1 sales remained stable at SEK 51.2 million, but EBITDA fell due to non-recurring cost increases and accelerated depreciation. High-margin PiezoMotor nearly doubled sales, and new U.S. defense orders offset a lost med tech deal. Cash flow and APAC growth are key focus areas.
Acuvi AB Quarterly report: Q1 2026
Acuvi AB has published its Q1 2026 quarterly earnings report on April 28, 2026.
Acuvi AB Earnings Call Transcript: Q4 2025
Net sales rose 25% in Q4 and 18% for the year, driven by deeper customer relationships and a shift to in-house sales. Adjusted EBITDA was positive, but non-recurring costs weighed on reported results. 2026 targets include 10% top-line growth and higher EBITDA, with focus on high-margin products and new markets.
Acuvi AB Quarterly report: Q4 2025
Acuvi AB has published its Q4 2025 quarterly earnings report on February 26, 2026.
Acuvi AB Annual report: Q4 2025
Acuvi AB has published its Q4 2025 annual report on February 26, 2026.
Acuvi AB Transcript: Business Update
A precision technology firm is shifting to direct sales in key markets to boost margins and customer engagement, while maintaining distributor partnerships in Asia. Financial targets remain unchanged, the company is now cash flow positive, and M&A is a strategic priority.
Acuvi AB Quarterly report: Q3 2025
Acuvi AB has published its Q3 2025 quarterly earnings report on October 28, 2025.